Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nancy Pelosi
Pharma
Build Back Better will only have a 'modest' impact on drugmakers
Only 10 fewer drugs are expected in the next 30 years if Biden's push for drug pricing negotiations makes its way into law.
Fraiser Kansteiner
Nov 19, 2021 8:59am
PhRMA lashes out at prospect of Medicare negotiating drug prices
Jul 16, 2021 8:39am
Congress has 'time-limited' chance to fix high drug costs
Jul 14, 2021 10:40am
New Alzheimer's drug gives price reformers their poster child
Jun 10, 2021 10:29am
FiercePharmaPolitics— Lawmakers want a pricing win in 2020
Jan 13, 2020 9:21am
After years of pricing scrutiny, how will pharma fare in 2020?
Dec 19, 2019 3:00pm
